The "rapid decliner" COPD phenotype Source: Annual Congress 2010 - COPD: diagnosis Year: 2010
Desmosin as a marker for tissue injury in COPD Source: Annual Congress 2007 - α1 -Antitrypsin deficiency: molecular and clinical news Year: 2007
Cardiovascular comorbidities prevails in the early stages of COPD irrespective of predominant airway or emphysema phenotype Source: Annual Congress 2013 –COPD treatment Year: 2013
Impact of a single chronic obstructive pulmonary disease (COPD) exacerbation on lung function decline: Analysis of UPLIFT® Source: Annual Congress 2012 - Exacerbations of asthma and COPD: assessment, impact and novel treatments Year: 2012
The bronchitic phenotype is associated with frequent exacerbations in COPD irrespective of chronic bacterial airway infection Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013
The "susceptibility to exacerbation" phenotype in COPD and response to pulmonary rehabilitation Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011
To study the severity of lung hyperinflation and bone mineral density in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –COPD mechanisms Year: 2013
Distinct clinical phenotypes of airways disease defined by cluster analysis Source: Eur Respir J 2009; 34: 812-818 Year: 2009
Pulmonary function response in smokers and patients with chronic obstructive lung disease (COPD) following exposure to concentrated fine (PM2.5 ) particles Source: Annual Congress 2009 - Indoor and outdoor air pollution Year: 2009
In active and former smokers with CT detected emphysema but without airway obstruction, the presence of an abnormal DLco is associated with a worse clinical presentation Source: International Congress 2016 – Non-inflammatory COPD monitoring Year: 2016
Functional single nucleotide polymorphisms of the CCL5 gene and nonemphysematous phenotype in COPD patients Source: Eur Respir J 2008; 32: 372-378 Year: 2008
Phenotypic markers of asthma and COPD at the tissue level Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005
Why is it important to consider (sub)phenotypes of asthma and COPD? Source: Annual Congress 2005 - Inflammatory phenotypes of asthma and COPD: the end of traditional diagnosis, or not? Year: 2005
Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: Annual Congress 2013 –The best posters in chronic care Year: 2013
The relationship between fibroblasts and airway structure in patients with asthma and chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2001; 18: Suppl. 33, 148s Year: 2001
Variability and effects of bronchial colonization on symptoms and lung function in moderate COPD Source: Annual Congress 2006 - Clinical aspects and treatment of lower respiratory infection in COPD patients Year: 2006
Characterization of COPD phenotype: comparison of the perceptual response to exercise in emphysema and chronic bronchitis patients Source: Annual Congress 2008 - Respiratory muscles in disease Year: 2008
The role of CD4/CD8 ratio in development of chronic obstructive pulmonary disease (COPD) among smokers Source: Eur Respir J 2002; 20: Suppl. 38, 94s Year: 2002
Irisin is associated with severe exacerbations of COPD independently of lung function, comorbidities and exercise capacity Source: International Congress 2015 – Notable abstracts in COPD: variety Year: 2015
Can chronic obstructive lung disease (COPD) criteria be used to manage bronchiectasis (BR) and obliterative bronchiolitis (OB) in children surviving severe lung infection? Source: Eur Respir J 2001; 18: Suppl. 33, 172s Year: 2001